Back
Aligos Therapeutics Stock Price Chart
Buy these stocks BEFORE President Trump returns to the Oval Office
See details on which stocks are poised to surge.
Buy
69
ALGS
Aligos Therapeutics
Last Price:
19.46
Seasonality Move:
0%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.
Aligos Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.51 | Buy |
| 20-day SMA: | 10.04 | Buy |
| 50-day SMA: | 10.1 | Buy |
| 200-day SMA: | 15.29 | Buy |
| 8-day EMA: | 13.81 | Buy |
| 20-day EMA: | 11.23 | Buy |
| 50-day EMA: | 10.58 | Buy |
| 200-day EMA: | 14.46 | Buy |
Aligos Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.73 | Buy |
| Relative Strength Index (14 RSI): | 85.55 | Buy |
| Chaikin Money Flow: | -389523 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
Aligos Therapeutics Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Aligos Therapeutics Stock
Is Aligos Therapeutics Stock a Buy?
- Aligos Therapeutics share price is 19.45 while ALGS 8-day simple moving average is 12.51, which is a Buy signal.
- The stock price of ALGS is 19.45 while Aligos Therapeutics 20-day SMA is 10.04, which makes it a Buy.
- Aligos Therapeutics 50-day simple moving average is 10.10 while ALGS share price is 19.45, making it a Buy technically.
- ALGS stock price is 19.45 and Aligos Therapeutics 200-day simple moving average is 15.29, creating a Buy signal.
ALGS Technical Analysis vs Fundamental Analysis
Buy
69
Aligos Therapeutics (ALGS)
is a Buy
Is Aligos Therapeutics a Buy or a Sell?
-
Aligos Therapeutics stock is rated a Buy
The current Aligos Therapeutics [ALGS] share price is $19.45. The Score for ALGS is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
Aligos Therapeutics Stock Info
Market Cap:
69.78M
Price in USD:
19.45
Share Volume:
1.21M
Aligos Therapeutics 52-Week Range
52-Week High:
30.00
52-Week Low:
6.76
Buy
69
Aligos Therapeutics (ALGS)
is a Buy
Aligos Therapeutics Share Price Forecast
-
What is the Aligos Therapeutics stock price today?
The Aligos Therapeutics stock price is 19.45 USD today. -
Will ALGS stock go up or go down?
Aligos Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Aligos Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Aligos Therapeutics is not overvalued.
Is Aligos Therapeutics Stock a Buy?
- Aligos Therapeutics share price is 19.45 while ALGS 8-day exponential moving average is 13.81, which is a Buy signal.
- The stock price of ALGS is 19.45 while Aligos Therapeutics 20-day EMA is 11.23, which makes it a Buy.
- Aligos Therapeutics 50-day exponential moving average is 10.58 while ALGS share price is 19.45, making it a Buy technically.
- ALGS stock price is 19.45 and Aligos Therapeutics 200-day simple moving average is 14.46, creating a Buy signal.
Fundamental Analysis of Aligos Therapeutics
Is Aligos Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.
Technical Analysis of Aligos Therapeutics
Should I short Aligos Therapeutics stock?
- ALGS Moving Average Covergence Divergence (MACD) indicator is 1.73, suggesting Aligos Therapeutics is a Buy
- Aligos Therapeutics Relative Strength Index (RSI) is 85.55, which suggest Aligos Therapeutics is overbought
- The Bollinger Bands (25) for Aligos Therapeutics is ( - ), which suggest Aligos Therapeutics is a Buy
- The Bollinger Bands (100) for Aligos Therapeutics is ( - ), which suggest Aligos Therapeutics is a Buy
* Aligos Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.